[1] Bence, K.K., Delibegovic, M., Xue, B., Gorgun, C.Z., Hotamisligil, G.S.,
. (2006).
Nat Med 12, 917-924 .
10.1038/nm1435[2] Delibegovic, M., Zimmer, D., Kauffman, C., Rak, K., Hong, E.G.,
. (2009).
Diabetes 58, 59-599 .
[3] Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S.,
. (1999).
Science 283, 154-1548 .
10.1126/science.283.5407.1544[4] Goldstein, B.J. (2001).
Curr Drug Targets Immune Endocr Metabol Disord 1, 26-275 .
10.2174/1568008013341163[5] Noell, W.K., Walker, V.S., Kang, B.S., and Berman, S. (1966).
Invest Ophthalmol 5, 45-473 .
[6] Punzo, C., Kornacker, K., and Cepko, C.L. (2009).
Nat Neurosci 12, 4-52 .
10.1038/nn.2234[7] Rajala, A., Anderson, R.E., Ma, J.X., Lem, J., Al Ubaidi, M.R.,
. (2007).
J Biol Chem 282, 986-9873 .
10.1074/jbc.M608845200[8] Rajala, A., Dighe, R., Agbaga, M.P., Anderson, R.E., and Rajala, R.V. (2013).
J Biol Chem 288, 1950-19515 .
10.1074/jbc.M113.469064[9] Rajala, A., Tanito, M., Le, Y.Z., Kahn, C.R., and Rajala, R.V. (2008).
J Biol Chem 283, 1978-19792 .
10.1074/jbc.M802374200[10] Rajala, R.V., Tanito, M., Neel, B.G., and Rajala, A. (2010).
J Biol Chem 285, 889-8904 .
10.1074/jbc.M109.070854[11] Rajala, R.V., Wiskur, B., Tanito, M., Callegan, M., and Rajala, A. (2009).
Invest Ophthalmol Vis Sci 50, 103-1040 .
[12] Tonks, N.K. (2003).
FEBS Lett 546, 14-148 .
10.1016/S0014-5793(03)00603-3[13] Xue, B., Pulinilkunnil, T., Murano, I., Bence, K.K., He, H.,
. (2009).
Mol Cell Biol 29, 4563-4573 .
10.1128/MCB.01914-08[14] Zinker, B.A., Rondinone, C.M., Trevillyan, J.M., Gum, R.J., Clampit, J.E.,
. (2002).
Proc Natl Acad Sci U S A 99, 11357-11362 .
10.1073/pnas.142298199